AU6108399A - Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins - Google Patents

Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins

Info

Publication number
AU6108399A
AU6108399A AU61083/99A AU6108399A AU6108399A AU 6108399 A AU6108399 A AU 6108399A AU 61083/99 A AU61083/99 A AU 61083/99A AU 6108399 A AU6108399 A AU 6108399A AU 6108399 A AU6108399 A AU 6108399A
Authority
AU
Australia
Prior art keywords
inhibitors
acid derivatives
phenylalkanoic acid
alpha4 integrins
alpha4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61083/99A
Other languages
English (en)
Inventor
Sarah Catherine Archibald
John Clifford Head
John Robert Porter
Graham John Warrellow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of AU6108399A publication Critical patent/AU6108399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AU61083/99A 1998-10-01 1999-09-30 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins Abandoned AU6108399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9821406.7A GB9821406D0 (en) 1998-10-01 1998-10-01 Chemical compounds
GB9821406 1998-10-01
PCT/GB1999/003243 WO2000020396A1 (fr) 1998-10-01 1999-09-30 Derives d'acide phenylalcanoique comme inhibiteurs d'integrines alpha-4

Publications (1)

Publication Number Publication Date
AU6108399A true AU6108399A (en) 2000-04-26

Family

ID=10839820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61083/99A Abandoned AU6108399A (en) 1998-10-01 1999-09-30 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins

Country Status (5)

Country Link
EP (1) EP1117646A1 (fr)
JP (1) JP2002526533A (fr)
AU (1) AU6108399A (fr)
GB (1) GB9821406D0 (fr)
WO (1) WO2000020396A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273273T1 (de) 1998-02-26 2004-08-15 Celltech Therapeutics Ltd Phenylalaninderivate als inhibitoren von alpha4 integrinen
GB9811969D0 (en) 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
SK8692002A3 (en) 1999-12-28 2003-06-03 Pfizer Prod Inc Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
US6403608B1 (en) * 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6960597B2 (en) 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
US7015216B2 (en) 2000-07-21 2006-03-21 Elan Pharmaceuticals, Inc. Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
GB0021898D0 (en) * 2000-09-06 2000-10-25 Celltech Chiroscience Ltd Chemical compounds
CA2938945A1 (fr) 2014-03-13 2015-09-17 Prothena Biosciences Limited Polytherapie pour la sclerose en plaques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609718B2 (ja) * 1977-08-25 1985-03-12 塩野義製薬株式会社 チアジアゾリルチオセフアロスポリン類縁抗生物質
JPH07503944A (ja) * 1991-11-22 1995-04-27 イエダ　リサーチ　アンド　デベロツプメント　カンパニー　リミテツド Ａｒｇ−ｇｌｙ−ａｓｐ配列の非ペプチド代替物およびそれらからなる医薬組成物

Also Published As

Publication number Publication date
JP2002526533A (ja) 2002-08-20
GB9821406D0 (en) 1998-11-25
WO2000020396A1 (fr) 2000-04-13
EP1117646A1 (fr) 2001-07-25

Similar Documents

Publication Publication Date Title
HUP0101793A3 (en) Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
AU1283200A (en) Propanoic acid derivatives as integrin inhibitors
AU4458700A (en) Uses of phenylglycine derivatives
AU2001267854A1 (en) Novel dicarboxylic acid derivatives
AU4201799A (en) Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
AU2001290075A1 (en) Novel alkanoic acid derivatives
AU5634999A (en) Hydroxamic acid derivatives as proteinase inhibitors
AU4276599A (en) Phenylalanine derivatives as integrin inhibitors
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
AU2002222552A1 (en) Substituted carboxylic acid derivatives
AU2002222574A1 (en) Substituted carboxylic acid derivatives
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2199401A (en) Propanoic acid derivatives as integrin inhibitors
AU6108399A (en) Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins
AU1268400A (en) Isothiazolecarboxylic acid derivatives
AU2001286163A1 (en) An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
AU3602499A (en) Indole derivatives suitable to be used as chromogenic compounds
AU2002222573A1 (en) Substituted carboxylic acid derivatives
AU2002222550A1 (en) Substituted carboxylic acid derivatives
AU2938997A (en) Subsituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
AUPR195900A0 (en) Detection of compounds such as thyroxine
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives
AU6484599A (en) An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
AU3620099A (en) Aminomethyl-benzoic ester derivatives as tryptase inhibitors
AU5993098A (en) Novel boronic acid derivatives inhibitors of angiogenesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase